Corinthian Colleges and DeVry Surge as Pell Grant Program Expected to Run a Surplus in 2013 and 2014

Five Star Equities Provides Stock Research on Corinthian Colleges and DeVry

Continue Reading

Solar Industry Impressing Investors With Gains After Dismal 2012

RDInvesting Provides Stock Research on Trina Solar and Yingli Green Energy

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on StemCells and ZIOPHARM Oncology

Continue Reading

First Solar and SunPower Surge After Receiving “Buy” Rating From CitiGroup

RDInvesting Provides Stock Research on First Solar and SunPower

Continue Reading

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Research Driven Investing Provides Stocks Research on ArQule and BioCryst Pharmaceuticals

Continue Reading

Steadily Improving U.S. Housing Market Continues to Increase Appeal of High Yielding REITs

Five Star Equities Provides Stock Research on Invesco Mortgage Capital and Two Harbors Investment

Continue Reading

For-Profit Educators Look to Benefit as Pell Grant Program Not Expected to Receive Budget Cuts

Five Star Equities Provides Stock Research on Apollo Group and Career Education

Continue Reading

Gaming Stocks Look to Benefit as New Jersey Close to Becoming the Third State to Legalize Online Gambling

Five Star Equities Provides Stock Research on Bally Technologies and Glu Mobile

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Research Driven Investing Provides Stocks Research on Athersys and Rexahn Pharmaceuticals

Continue Reading